| Year |
Citation |
Score |
| 2016 |
Henein S, Swanstrom J, Byers AM, Moser JM, Shaik SF, Bonaparte M, Jackson N, Guy B, Baric R, de Silva AM. Dissecting antibodies induced by a chimeric yellow fever-dengue, live-attenuated, tetravalent dengue vaccine (CYD-TDV) in naïve and dengue exposed individuals. The Journal of Infectious Diseases. PMID 27932620 DOI: 10.1093/Infdis/Jiw576 |
0.69 |
|
| 2015 |
Byers AM, Broder R, Haupfear K, Timiryasova TM, Hu BT, Boaz M, Warren WL, Jackson N, Moser JM, Guy B. Influence of FcγRIIa-Expressing Cells on the Assessment of Neutralizing and Enhancing Serum Antibodies Elicited by a Live-Attenuated Tetravalent Dengue Vaccine. Open Forum Infectious Diseases. 2: ofv172. PMID 26719844 DOI: 10.1093/ofid/ofv172 |
0.728 |
|
| 2010 |
Moser JM, Sassano ER, Leistritz del C, Eatrides JM, Phogat S, Koff W, Drake DR. Optimization of a dendritic cell-based assay for the in vitro priming of naïve human CD4+ T cells. Journal of Immunological Methods. 353: 8-19. PMID 19925804 DOI: 10.1016/J.Jim.2009.11.006 |
0.728 |
|
| 2009 |
Higbee RG, Byers AM, Dhir V, Drake D, Fahlenkamp HG, Gangur J, Kachurin A, Kachurina O, Leistritz D, Ma Y, Mehta R, Mishkin E, Moser J, Mosquera L, Nguyen M, et al. An immunologic model for rapid vaccine assessment -- a clinical trial in a test tube. Alternatives to Laboratory Animals : Atla. 37: 19-27. PMID 19807200 DOI: 10.1177/026119290903701S05 |
0.713 |
|
| 2008 |
Gaucher D, Therrien R, Kettaf N, Angermann BR, Boucher G, Filali-Mouhim A, Moser JM, Mehta RS, Drake DR, Castro E, Akondy R, Rinfret A, Yassine-Diab B, Said EA, Chouikh Y, et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. The Journal of Experimental Medicine. 205: 3119-31. PMID 19047440 DOI: 10.1084/Jem.20082292 |
0.633 |
|
| 2008 |
Evans AG, Moser JM, Krug LT, Pozharskaya V, Mora AL, Speck SH. A gammaherpesvirus-secreted activator of Vbeta4+ CD8+ T cells regulates chronic infection and immunopathology. The Journal of Experimental Medicine. 205: 669-84. PMID 18332178 DOI: 10.1084/Jem.20071135 |
0.644 |
|
| 2008 |
Gargano LM, Moser JM, Speck SH. Role for MyD88 signaling in murine gammaherpesvirus 68 latency. Journal of Virology. 82: 3853-63. PMID 18256152 DOI: 10.1128/Jvi.02577-07 |
0.368 |
|
| 2007 |
Krug LT, Moser JM, Dickerson SM, Speck SH. Inhibition of NF-kappaB activation in vivo impairs establishment of gammaherpesvirus latency. Plos Pathogens. 3: e11. PMID 17257062 DOI: 10.1371/Journal.Ppat.0030011 |
0.42 |
|
| 2006 |
Moser JM, Farrell ML, Krug LT, Upton JW, Speck SH. A gammaherpesvirus 68 gene 50 null mutant establishes long-term latency in the lung but fails to vaccinate against a wild-type virus challenge. Journal of Virology. 80: 1592-8. PMID 16415035 DOI: 10.1128/Jvi.80.3.1592-1598.2006 |
0.311 |
|
| 2005 |
Moser JM, Upton JW, Allen RD, Wilson CB, Speck SH. Role of B-cell proliferation in the establishment of gammaherpesvirus latency. Journal of Virology. 79: 9480-91. PMID 16014911 DOI: 10.1128/Jvi.79.15.9480-9491.2005 |
0.333 |
|
| 2005 |
Moser JM, Upton JW, Gray KS, Speck SH. Ex vivo stimulation of B cells latently infected with gammaherpesvirus 68 triggers reactivation from latency. Journal of Virology. 79: 5227-31. PMID 15795307 DOI: 10.1128/Jvi.79.8.5227-5231.2005 |
0.415 |
|
| 2003 |
Byers AM, Kemball CC, Moser JM, Lukacher AE. Cutting edge: rapid in vivo CTL activity by polyoma virus-specific effector and memory CD8+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 171: 17-21. PMID 12816977 DOI: 10.4049/Jimmunol.171.1.17 |
0.709 |
|
| 2002 |
Moser JM, Byers AM, Lukacher AE. NK cell receptors in antiviral immunity. Current Opinion in Immunology. 14: 509-16. PMID 12088687 DOI: 10.1016/S0952-7915(02)00357-6 |
0.768 |
|
| 2002 |
Moser JM, Gibbs J, Jensen PE, Lukacher AE. CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses. Nature Immunology. 3: 189-95. PMID 11812997 DOI: 10.1038/Ni757 |
0.766 |
|
| 2001 |
Daniels MA, Devine L, Miller JD, Moser JM, Lukacher AE, Altman JD, Kavathas P, Hogquist KA, Jameson SC. CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation. Immunity. 15: 1051-61. PMID 11754824 DOI: 10.1016/S1074-7613(01)00252-7 |
0.724 |
|
| 2001 |
Moser JM, Lukacher AE. Immunity to polyoma virus infection and tumorigenesis. Viral Immunology. 14: 199-216. PMID 11572632 DOI: 10.1089/088282401753266738 |
0.777 |
|
| 2001 |
Moser JM, Altman JD, Lukacher AE. Antiviral CD8+ T cell responses in neonatal mice: susceptibility to polyoma virus-induced tumors is associated with lack of cytotoxic function by viral antigen-specific T cells. The Journal of Experimental Medicine. 193: 595-606. PMID 11238590 DOI: 10.1084/Jem.193.5.595 |
0.765 |
|
| 2000 |
Pertmer TM, Oran AE, Moser JM, Madorin CA, Robinson HL. DNA vaccines for influenza virus: differential effects of maternal antibody on immune responses to hemagglutinin and nucleoprotein. Journal of Virology. 74: 7787-93. PMID 10933685 DOI: 10.1128/Jvi.74.17.7787-7793.2000 |
0.443 |
|
| 2000 |
Drake DR, Moser JM, Hadley A, Altman JD, Maliszewski C, Butz E, Lukacher AE. Polyomavirus-infected dendritic cells induce antiviral CD8(+) T lymphocytes. Journal of Virology. 74: 4093-101. PMID 10756021 DOI: 10.1128/Jvi.74.9.4093-4101.2000 |
0.794 |
|
| 1999 |
Lukacher AE, Moser JM, Hadley A, Altman JD. Visualization of polyoma virus-specific CD8+ T cells in vivo during infection and tumor rejection. Journal of Immunology (Baltimore, Md. : 1950). 163: 3369-78. PMID 10477607 |
0.768 |
|
| 1999 |
Wilson CS, Moser JM, Altman JD, Jensen PE, Lukacher AE. Cross-recognition of two middle T protein epitopes by immunodominant polyoma virus-specific CTL. Journal of Immunology (Baltimore, Md. : 1950). 162: 3933-41. PMID 10201912 |
0.653 |
|
| Show low-probability matches. |